| Literature DB >> 34219482 |
Maria L Salvetat1, Carlo Salati2, Patrizia Busatto1, Marco Zeppieri2.
Abstract
PURPOSE: To assess ocular pathologies admitted to Italian Emergency Eye Departments (EEDs) during the COVID-19 pandemic national lockdown in 2020 in comparison with the same period in 2019.Entities:
Keywords: COVID-19; SARS-CoV-2; eye emergency; lockdown; pandemic
Mesh:
Year: 2021 PMID: 34219482 PMCID: PMC9111919 DOI: 10.1177/11206721211028046
Source DB: PubMed Journal: Eur J Ophthalmol ISSN: 1120-6721 Impact factor: 1.922
Figure 1.Bar chart showing the average number of patients presenting to the Emergency Eye Department per week during the COVID-19 related pandemic lockdown in Italy (March 10–May 3, 2020), compared to the equivalent period in 2019.
Figure 2.(a) Bar chart of age distribution (number of cases in each age rank) of patients presenting to the Emergency Eye Department during the COVID-19 related pandemic lockdown in Italy (March 10–May 3, 2020), compared to the equivalent period in 2019. (b) Bar chart of gender distribution (% of total caseload) of patients presenting to the Emergency Eye Department during the COVID-19 related pandemic lockdown in Italy (March 10–May 3, 2020), compared to the equivalent period in 2019.
Incidence of the top diagnoses presenting at the Emergency Eye Department.
| Diagnoses | 2019 Equivalent period
(10th March 2019–3rd May 2019) | 2020 COVID-19 lockdown
(10th March 2020–3rd May 2020) | Inter-group differences | |||||
|---|---|---|---|---|---|---|---|---|
| 2020 minus 2019 | 2020 versus 2019 | |||||||
| No. of cases | Males/females (%) | Age (years), (mean ± SD) | No. of cases | Males/females (%) | Age (years), (mean ± SD) | No. of cases (% of total cases of 2019) | No. of cases ( | |
| Total number of cases | 1854 | 55.8/44.2 | 53.3 ± 22.6 | 851 | 61.1/38.9 | 52.8 ± 20.4 | −54.1 | <0.000 |
| All types of eye inflammation | 702 | 51.7/48.4 | 55.6 ± 21 | 242 | 43.4/56.6 | 50 ± 24 | −65.5 | <0.000 |
| All types of eye trauma | 541 | 67.7/32.2 | 45.5 ± 21.4 | 334 | 74/26 | 45.1 ± 23 | −38.3 | 0.026 |
| Blepharoconjunctivitis/conjunctivitis | 360 | 48.9/51.1 | 53.3 ± 22.8 | 143 | 47.4/52.6 | 47.7 ± 22.5 | −60.3 | 0.015 |
| Foreign body on external eye | 327 | 81.1/18.8 | 46 ± 16.6 | 200 | 88.5/11.5 | 44.6 ± 15.2 | −38.8 | 0.045 |
| Spontaneous acute vitreal detachment | 132 | 31.1/68.9 | 66.4 ± 8.9 | 62 | 32.3/67.7 | 63.6 ± 10.1 | −53.0 | 0.88 |
| Corneal abrasion | 117 | 63.2/36.8 | 45.5 ± 20.3 | 45 | 68.9/31.1 | 47.3 ± 16 | −61.5 | 0.31 |
| Eyeball contusion | 108 | 72.7/27.3 | 39.4 ± 28.3 | 39 | 50/50 | 43.3 ± 29.3 | −63.9 | 0.97 |
| Headache/hemicranic aura | 93 | 46.8/53.2 | 25.8 ± 24.6 | 22 | 75/25 | 26 ± 28.1 | −76.3 | 0.001 |
| Spontaneous subconjunctival hemorrhage | 82 | 50/50 | 65.2 ± 16.8 | 14 | 71.4/28.6 | 67.7 ± 9.9 | −82.9 | 0.001 |
| Chalazion | 61 | 39.3/60.7 | 48.3 ± 21.8 | 23 | 52.2/47.8 | 49.1 ± 21.6 | −62.3 | 0.42 |
| Eyelid/conjunctival/corneal wound | 61 | 53.6/46.4 | 51.2 ± 20.5 | 30 | 62/38 | 50.4 ± 16.6 | −50.8 | 0.75 |
| AMD- or other causes-related active CNV | 47 | 28.9/71.1 | 76.9 ± 14 | 29 | 22.2/77.8 | 76 ± 11.4 | −38.3 | 0.08 |
| Herpes zoster ophthalmicus | 41 | 51.2/48.8 | 61.7 ± 19.5 | 26 | 38.5/61.5 | 63.7 ± 17.9 | −36.6 | 0.2 |
| Keratitis/corneal ulcer | 37 | 64.9/35.1 | 60.3 ± 19.9 | 26 | 69.2/30.8 | 47.3 ± 22.1 | −29.7 | 0.1 |
| Ocular hypertension/glaucoma | 36 | 40/60 | 77.1 ± 9.3 | 11 | 33.3/66.7 | 72.3 ± 12.7 | −69.4 | 0.36 |
| Refractive errors | 27 | 33.3/66.7 | 39.7 ± 25.7 | 5 | 80/20[ | 37.4 ± 19.9[ | −81.5 | 0.06 |
| Retinal ruptures/degenerations | 25 | 56/44 | 63.6 ± 15 | 13 | 61.5/38.5 | 54.6 ± 12.4 | −48.0 | 0.71 |
| Vitreal floaters | 24 | 58.3/41.7 | 55.7 ± 17 | 6 | 50/50[ | 48.5 ± 15[ | −75.0 | 0.18 |
| Cataract/posterior capsule opacification | 23 | 46.7/53.3 | 67.7 ± 14.2 | 12 | 50/50 | 76.5 ± 12.8 | −47.8 | 0.73 |
| Optic nerve/retinal vascular occlusion | 20 | 42.9/57.1 | 71.3 ± 12.7 | 14 | 80/20 | 66.4 ± 9 | −30.0 | 0.48 |
| Dry eye | 19 | 15.8/84.2 | 70.3 ± 16.1 | 3 | 33.3/66.7[ | 56.7 ± 10.3[ | −84.2 | 0.09 |
| Uveitis | 18 | 52.9/47.1 | 50.5 ± 19.3 | 12 | 50/50 | 48.7 ± 23.4 | −33.3 | 0.25 |
| Retinal detachment | 18 | 86.7/13.3 | 65.6 ± 12.7 | 14 | 58.3/41.7 | 59.9 ± 12.8 | −22.2 | 0.15 |
| Neurological disorders | 17 | 52/48 | 32.2 ± 30 | 20 | 83.3/16.7 | 50 ± 24.3 | 17.6 | 0.11 |
| Trichiasis | 17 | 52.9/47.1 | 69.6 ± 20.3 | 8 | 50/50 | 70.5 ± 10.6 | −52.9 | 0.95 |
| Post-operative complications | 15 | 20/80 | 69.7 ± 15.3 | 1 | 0/100[ | 53[ | −93.3 | 0.06 |
| Vitreous hemorrhage | 12 | 60/40 | 73.5 ± 19.8 | 8 | 25/75 | 73 ± 14.1 | −33.3 | 0.82 |
SD: standard deviation; CNV: choroidal neovascularization.
Statistically significant effect of gender on the diagnose (Poisson regression for count).
Statistically significant effect of age on the diagnose (Poisson regression for count).
Poisson regression for count.
Statistically significant difference in the number of cases between study periods.
Not applicable for low number of cases.
Figure 3.Bar chart of the most frequent diagnoses (as percentage of total caseload) of patients presenting to the Emergency Eye Department during the COVID-19 related pandemic lockdown in Italy (March 10–May 3, 2020), compared to the equivalent period in 2019.
*Statistically significant difference between groups.
Incidence of the top diagnoses presenting at Emergency eye Department shown as percentages of total caseload.
| Diagnoses | 2019 | 2020 | Chi[ |
|---|---|---|---|
| % of total cases | |||
| All types of eye inflammation | 37.86 | 28.44 | 0.018 |
| All types of eye trauma | 29.18 | 38.25 | 0.016 |
| Blepharoconjunctivitis/conjunctivitis | 19.42 | 16.8 | 0.032 |
| Foreign body on external eye | 17.64 | 23.5 | <0.0001 |
| Spontaneous acute vitreal detachment | 7.12 | 7.29 | 0.87 |
| Corneal abrasion | 6.31 | 5.29 | 0.34 |
| Eyeball contusion | 5.83 | 4.58 | 0.42 |
| Headache/hemicranic aura | 5.02 | 2.59 | 0.49 |
| Spontaneous subconjunctival hemorrhage | 4.42 | 1.65 | <0.0001 |
| Chalazion | 3.29 | 2.7 | 0.47 |
| Eyelid/conjunctival/corneal wound | 3.29 | 3.53 | 0.20 |
| AMD- or other causes-related active CNV | 2.54 | 3.41 | 0.08 |
| Herpes zoster ophthalmicus | 2.21 | 3.06 | 0.23 |
| Keratitis/corneal ulcer | 2.00 | 3.06 | 0.10 |
| Ocular hypertension/glaucoma | 1.94 | 1.29 | 0.40 |
| Refractive errors | 1.46 | 0.59 | 0.06 |
| Retinal ruptures/degenerations | 1.35 | 1.53 | 0.73 |
| Vitreal floaters | 1.29 | 0.71 | 0.23 |
| Cataract/posterior capsule opacification | 1.24 | 1.41 | 0.82 |
| Optic nerve/retinal vascular occlusion | 1.08 | 1.65 | 0.53 |
| Dry eye | 1.02 | 0.35 | 0.11 |
| Uveitis | 0.97 | 1.41 | 0.31 |
| Retinal detachment | 0.97 | 1.65 | 0.15 |
| Neurological disorders | 0.92 | 2.35 | 0.11 |
| Trichiasis | 0.92 | 0.94 | 1.00 |
| Post-operative complications | 0.81 | 0.12 | 0.18 |
| Vitreous hemorrhage | 0.65 | 0.94 | 0.10 |
CNV: choroidal neovascularization.
Figure 4.Bar chart of the percentages of patients presenting to the Emergency Eye Department during the COVID-19 related pandemic lockdown in Italy (March 10–May 3, 2020) and the equivalent period in 2019 classified as having urgent and non-urgent cases.
Incidence of emergency interventions and hospitalizations of patients presenting at the Emergency Eye Department.
| Procedures | 2019 equivalent period (10th March 2019–3rd May 2019), (number of cases) | 2020 COVID-19 lockdown (10th March 2020–3rd May 2020), (number of cases) | |
|---|---|---|---|
| Laser barrage for peripheral retinal breaks | 25 | 13 | 0.71 |
| Panretinal photocoagulation for proliferative diabetic retinopathy | 4 | 1 | na |
| Laser iridotomy for acute angle closure attack or occludible angle | 6 | 1 | na |
| Intravitreal anti-VEGF injection for | |||
| Neovascular glaucoma | 4 | 1 | na |
| Active choroidal neovascular membrane | 47 | 29 | 0.08 |
| Ischemic retinal vein occlusion | 13 | 8 | 0.69 |
| Diabetic macular edema | 9 | 2 | 0.22 |
| Hospitalization for ocular surgery in | |||
| Retinal detachment | 18 | 14 | 0.15 |
| Corneo-scleral sutures for traumatic eye perforation | 1 | 3 | na |
| Amniotic membrane application for corneal ulcer | 2 | 1 | na |
| Total number of cases | 129 | 73 | 0.71 |
VEGF: vascular endothelial growth factor; na: not applicable for low number of cases.
Poisson regression for count.